An initial VSV-IFNβ variant drove tumor escape via a predictable CSDE1 (Cold Shock Domain-containing E1) mutation (CSDE1P5S) that enabled tumors to evade oncolytic virotherapy. The gene discussed is IFNB1; the disease is neoplasm.